Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04162106
Other study ID # Pro00103233
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 2019
Est. completion date February 2020

Study information

Verified date November 2019
Source Alesi Surgical Ltd.
Contact Jin S Yoo, MD
Phone 919-470-7038
Email sean.greene@duke.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This post-market clinical study is designed to evaluate the effectiveness of the Ultravision™ System when compared to the Airseal® iFS within an approved indication for use, namely laparoscopic cholosystectomy.


Description:

The primary hypothesis being tested in this study is that Ultravision facilitates the utilization of lower pneumoperitoneal pressures whilst maintaining an adequate visual field throughout the procedure with low demand for CO2 replenishment to maintain pneumoperitoneal pressure. Comparisons in terms of surgical field visualization, procedure times, and CO2 consumption will be conducted in order to determine whether or not any clinical benefits are derived from the use of the Ultravision™ System compared to the Airseal® iFS. Low pressure laparoscopy for this study is set at 10mmHg. This is a prospective, open-label, randomized controlled study. The study will include two study arms. Patients undergoing laparoscopic cholecystectomy will be randomized to either "Ultravision" (study arm 1) or Airseal® iFS (study arm 2). Both groups will conduct the procedure at 10mmHg, considered to be low pressure/low impact laparoscopic surgery. The study will enroll 30 patients, 15 per group. Both devices are being used according to their cleared label claims.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date February 2020
Est. primary completion date January 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Is 18 years or older

- Provide written informed consent prior to trial procedures after studies indicate that the patient needs the prescribed procedure

- Agrees to attend all follow-up assessments

- Is indicated for elective laparoscopic cholecystectomy

Exclusion Criteria:

- Existing comorbidities that would contraindicate them for laparoscopic surgery

- Patient anatomy i.e. abdominal wall thickness that exceeds the working length of the Ionwand catheter identified intraoperatively

- Body Mass Index > 50

- Be pregnant (if female)

- Has a condition of unrelated chronic pain requiring medication

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Smoke management during laparoscopic cholecystectomy using the Ultravision™ System
The Ultravision™ System will be used during the procedure to manage smoke generated as a result of the use of diathermy.
Smoke management during laparoscopic cholecystectomy using the Airseal® iFS
The Airseal® iFS will be used during the procedure to manage smoke generated as a result of the use of diathermy.

Locations

Country Name City State
United States Duke Regional Hospital Durham North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Alesi Surgical Ltd.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Carbon Dioxide Utilization The volume measured in Liters of Carbon Dioxide consumed during the procedure Measured from Veress needle insertion to just prior to gall bladder removal
Primary Quality of Visualization The quality of visualization in the laparoscopic field Measured from camera insertion through removal
Secondary Procedure time for Diathermy use Measures the procedure time in minutes where diathermy is used Measured from the exposure and identification of the cystic duct and artery is complete to the last use of diathermy
Secondary Diathermy Power Setting Highest diathermy setting used during the procedure Measured from the exposure and identification of the cystic duct and artery is complete to the last use of diathermy
Secondary Procedure Time Overall procedure time in minutes Measured from the insertion of the camera to the time of closure
Secondary End tidal CO2 Volume End tidal volume of CO2 Measured at Veress needle insertion and just prior to gall bladder removal
Secondary Laparoscope cleaning The number of times during the procedure that the laparoscope must be removed for cleaning to maintain visual field Measured from the exposure and identification of the cystic duct and artery is complete to the last use of diathermy
Secondary Pneumoperitoneum Pressure The pneumoperitoneum pressure during the procedure and record of any increase beyond 10mmHg for visualization Starting pneumoperitoneum pressure at the time of camera trocar insertion, record the maximum pressure that occurred during the procedure
Secondary Trocar Venting The number of times the trocar is used to vent during the procedure for visualization Measured from the exposure and identification of the cystic duct and artery is complete to the last use of diathermy
Secondary Case Complexity Case complexity compared to surgeon experience. Recorded as simple or routine or complex/difficult. Immediately post-procedure
Secondary Pain Assessment Pre and Post operative pain surveys Pre-procedure and 1 to 7 days post procedure
Secondary Pain Medications Amount and type of pain medication administered and record of use following the procedure 1 to 7 days post procedure
See also
  Status Clinical Trial Phase
Completed NCT03670849 - Image Fusion in the OR N/A
Withdrawn NCT04561583 - Effectiveness and Safety of LED Light Source System for Endoscope N/A
Completed NCT00872287 - Pain in Single Incision Laparoscopic Surgery Cholecystectomy Phase 4
Recruiting NCT06017167 - Prophylaxis Against Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy Phase 2
Completed NCT05536557 - Bilateral External Oblique İntercostal (EOI) Plane Block in Patients Undergoing Laparoscopic Cholecystectomy. N/A
Recruiting NCT05794503 - Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex Early Phase 1
Completed NCT05998317 - Dexamethasone at Night vs at Induction on PONV After Laparoscopic Cholecystectomy Phase 2/Phase 3
Completed NCT04759079 - The Effects of Acupuncture Against Postoperative Nausea and Vomit After Laparoscopic Cholecystectomy N/A
Recruiting NCT04138472 - Comparison Of Dexmedetomidine, Fentanyl And Lignocaine In Attenuation Of Hemodynamic Response To Direct Laryngoscopy And Intubation In Patient Undergoing Laparoscopic Cholecystectomy N/A
Recruiting NCT06022926 - Investigation of the Intraoperative and Postoperative Effects of Warming Patients in Laparoscopic Cholecystectomy N/A
Completed NCT03067038 - Single Incision Versus Three Port Laparoscopic Cholecystectomy N/A
Completed NCT02469831 - Respiratory Mechanics and Metabolic Changes During Low Pressure Laparoscopic Cholecystectomy Phase 2
Completed NCT00886210 - Clinical Impact of Routine Abdominal Drainage After Laparoscopic Cholecystectomy N/A
Completed NCT00292214 - Comparing Intravenous and Oral Paracetamol for Cholecystectomy Phase 4
Recruiting NCT05533580 - Differential Effects of Remimazolam and Propofol on Dynamic Cerebral Autoregulation During General Anesthesia N/A
Recruiting NCT05533567 - Electroencephalographic Profiles During General Anesthesia: a Comparative Study of Remimazolam and Propofol N/A
Active, not recruiting NCT05636475 - The Effect Of Machine-Based And Manually Applied Hand Massage On Pain, Anxiety And Gastrointestinal System Functions After Laparoscopic Cholecystectomy Surgery N/A
Recruiting NCT05094193 - Trocar-site Infiltration Versus TAP-block N/A
Completed NCT03323684 - Quadratus Lumborum Block vs Transversus Abdominis Plane Block for Post-cholecystectomy Analgesia N/A
Unknown status NCT01041183 - The Effect of Oral and Intravenous Ramosetron During Laparoscopic Cholecystectomy N/A